Concentrations of IGF-I and IGFBP-3 and Brain Tumor Risk in the European Prospective Investigation into Cancer and Nutrition
暂无分享,去创建一个
E. Riboli | P. Vineis | A. Tjønneland | K. Overvad | N. Wareham | T. Key | P. Peeters | H. Bueno-De-Mesquita | A. Trichopoulou | D. Trichopoulos | K. Khaw | H. Boeing | R. Kaaks | D. Palli | S. Rohrmann | R. Tumino | D. Michaud | P. Lagiou | A. Olsen | E. Lund | S. Grioni | M. Dorronsoro | B. Melin | B. Schlehofer | V. Gallo | A. Mattiello | E. Ardanaz | L. Dossus | N. Allen | M. Chirlaque | J. Linseisen | L. Rodríguez | S. Rinaldi | F. V. van Duijnhoven | M. Sanchez | K. Aleksandrova | C. Bonet | D. Trichopoulos | F. V. Duijnhoven | I. Romieux | V. Grote | S. Becker | M. Sánchez | H. Bueno-de-Mesquita | S. Rinaldi
[1] I. Gram,et al. A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1 -2 and -3 in the European Prospective Investigation into Cancer and Nutrition (EPIC) , 2011, Annals of human biology.
[2] Andrew W Roddam,et al. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies , 2010, The Lancet. Oncology.
[3] F. Clavel-Chapelon,et al. Serum levels of IGF‐I, IGFBP‐3 and colorectal cancer risk: results from the EPIC cohort, plus a meta‐analysis of prospective studies , 2010, International journal of cancer.
[4] C. Koebnick,et al. Height, body mass index, and physical activity in relation to glioma risk. , 2009, Cancer research.
[5] P. Ye,et al. Expanding the mind: insulin-like growth factor I and brain development. , 2008, Endocrinology.
[6] François G. Meyer,et al. Insulin-like Growth Factors, Their Binding Proteins, and Prostate Cancer Risk: Analysis of Individual Patient Data from 12 Prospective Studies , 2008, Annals of Internal Medicine.
[7] Tarik Tihan,et al. Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium , 2008, Cancer.
[8] N. Rothman,et al. Genetic variation in insulin-like growth factors and brain tumor risk. , 2008, Neuro-oncology.
[9] D. Albanes,et al. Glioma Risk in Relation to Serum Levels of Insulin-Like Growth Factors , 2007, Cancer Epidemiology Biomarkers & Prevention.
[10] J. Trojan.,et al. Insulin-like growth factor type I biology and targeting in malignant gliomas , 2007, Neuroscience.
[11] Faith G Davis,et al. Descriptive epidemiology of vestibular schwannomas. , 2006, Neuro-oncology.
[12] P. Gluckman,et al. The insulin-like growth factor system and its pleiotropic functions in brain. , 2005, Endocrine reviews.
[13] A. Gore,et al. IGF-1 in the Brain as a Regulator of Reproductive Neuroendocrine Function , 2005, Experimental biology and medicine.
[14] S. Hankinson,et al. Insulin-like growth factors and neoplasia , 2004, Nature Reviews Cancer.
[15] Matthias Egger,et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis , 2004, The Lancet.
[16] J. Olsen,et al. Acromegaly and cancer risk: a cohort study in Sweden and Denmark , 2002, Cancer Causes & Control.
[17] T. Unterman,et al. Insulin-like growth factors in central nervous system tumors , 1997, Journal of Neuro-Oncology.
[18] T. Peters,et al. Do height-related variations in insulin-like growth factors underlie the associations of stature with adult chronic disease? , 2004, The Journal of clinical endocrinology and metabolism.
[19] P. Eriksson,et al. Insulin‐like growth factor‐I increases astrocyte intercellular gap junctional communication and connexin43 expression in vitro , 2003, Journal of neuroscience research.
[20] A. Miller,et al. Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) , 2002, Public Health Nutrition.
[21] W. Zumkeller. IGFs and IGF-binding proteins as diagnostic markers and biological modulators in brain tumors , 2002, Expert review of molecular diagnostics.
[22] P. Cohen,et al. Insulin-like growth factor binding protein-3 mediates tumor necrosis factor-alpha-induced apoptosis: role of Bcl-2 phosphorylation. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[23] M. Westphal,et al. The IGF/IGFBP system in CNS malignancy , 2001, Molecular pathology : MP.
[24] W. Pan,et al. Interactions of IGF-1 with the Blood-Brain Barrier in vivo and in situ , 2000, Neuroendocrinology.
[25] I. McCutcheon,et al. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. , 2000, Endocrine reviews.
[26] P. Cohen,et al. Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-β1 on Programmed Cell Death through a p53- and IGF-independent Mechanism* , 1997, The Journal of Biological Chemistry.
[27] Elio Riboli,et al. The EPIC Project: Rationale and study design , 1997 .
[28] N Slimani,et al. Pilot phase studies on the accuracy of dietary intake measurements in the EPIC project: overall evaluation of results. European Prospective Investigation into Cancer and Nutrition. , 1997, International journal of epidemiology.
[29] E Riboli,et al. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. , 1997, International journal of epidemiology.
[30] M. Ocké. European prospective investigation into cancer and nutrition. Voedingsnavraag in de EPIC studie. , 1996 .
[31] D. Clemmons,et al. Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.
[32] F. Naftolin,et al. Involvement of protein kinase-C in the mitogenic effect of insulin-like growth factor-I on rat astrocytes. , 1992, Endocrinology.